Professional Documents
Culture Documents
DOI 10.1099/vir.0.80718-0
Department of Infectious and Parasitic Diseases (B43b)1 and Food Sciences Department
(B43b)5, Faculty of Veterinary Medicine, University of Lie`ge, B-4000 Lie`ge, Belgium
Correspondence
A. Vanderplasschen
A.vdplasschen@ulg.ac.be
Several features make bovine herpesvirus 4 (BoHV-4) attractive as a backbone for use as a
viral expression vector and/or as a model to study gammaherpesvirus biology. However, these
developments have been impeded by the difficulty in manipulating its large genome using classical
homologous recombination in eukaryotic cells. In the present study, the feasibility of exploiting
bacterial artificial chromosome (BAC) cloning and prokaryotic recombination technology for
production of BoHV-4 recombinants was explored. Firstly, the BoHV-4 genome was BAC
cloned using two potential insertion sites. Both sites of insertion gave rise to BoHV-4 BAC
clones stably maintained in bacteria and able to regenerate virions when transfected into permissive
cells. Reconstituted virus replicated comparably to wild-type parental virus and the loxP-flanked
BAC cassette was excised by growing them on permissive cells stably expressing Cre
recombinase. Secondly, BoHV-4 recombinants expressing Ixodes ricinus anti-complement
protein I or II (IRAC I/II) were produced using a two-step mutagenesis procedure in Escherichia
coli. Both recombinants induced expression of high levels of functional IRAC molecules in the
supernatant of infected cells. This study demonstrates that BAC cloning and prokaryotic
recombination technology are powerful tools for the development of BoHV-4 as an expression
vector and for further fundamental studies of this gammaherpesvirus.
INTRODUCTION
Bovine herpesvirus 4 (BoHV-4) is a gammaherpesvirus that
has been isolated throughout the world from healthy cattle
as well as those exhibiting a variety of diseases (Thiry et al.,
1992). Its genome has a B-type structure consisting of a long
unique region (L-DNA) flanked by a total of 15 (on average,
as determined for the 66-p-347 strain) polyrepetitive DNA
(prDNA) elements distributed randomly at both ends of
the genome (Fig. 1a). The recent sequencing of BoHV-4
confirmed that it is a member of the genus Rhadinovirus
encoding a relatively reduced set of open reading frames
(ORFs) homologous to cellular genes (Zimmermann et al.,
2001).
3These authors contributed equally to this work.
Fig. 1. Schematic representation of the strategies followed to produce two infectious BoHV-4 BAC plasmids. (a, b) The
EcoRI restriction map of the entire BoHV-4 V. test strain is shown at the top. A loxP-flanked BAC cassette was inserted into
the XhoI (a) or BstEII (b) sites located, respectively, at the left and the right ends of BoHV-4 V. test strain L-DNA. These
regions do not contain any ORFs and are located, respectively, in the EcoRI G and EcoRI I restriction fragments of the
BoHV-4 V. test strain genome. (c) Flowchart of stages performed to produce BoHV-4 BAC plasmids, to control their
infectivity and to demonstrate the possibility of removing the loxP-flanked BAC cassette from the genome of reconstituted
virus.
908
METHODS
Cell lines and virus strains. MadinDarby bovine kidney
EBL cells stably expressing Cre recombinase fused to a nuclear localization signal (EBL NLSCre) were produced as follows. Briefly,
NLSCre was excised by NheI and SpeI digestion from the pGBFNLS-Cre vector (provided by Dr D. Pirottin, University of Lie`ge,
Belgium) and cloned into the XbaI site of the pEFIN3 bicistronic
expression vector (provided by Dr M. Parmentier, Free University of
http://vir.sgmjournals.org
910
IRAC molecules to inhibit the alternative pathway of the complement system was tested using the AH50 assay (Coligan et al., 1992).
Briefly, 50 ml unsensitized rabbit erythrocytes (Erab) [26108 cells
ml21 in ice cold gelatin/veronal-buffered saline with MgCl2 and
EGTA (GVB/Mg EGTA)] were added on ice to 20 ml human serum
and increasing amounts of the concentrated cell supernatant to be
tested. The final volume of each sample was made up to 150 ml with
GVB/Mg EGTA buffer. For background and total lysis samples,
100 ml GVB/Mg EGTA buffer and 100 ml water were added to the
50 ml Erab, respectively. After an incubation period of 60 min at
37 uC, 1?2 ml ice-cold 0?15 M NaCl was added to each sample to
stop haemolysis. After centrifugation at 1250 g for 10 min at 4 uC,
the supernatant was collected and its optical density measured at
412 nm (OD412). Relative haemolysis of each sample was calculated
as: (test sample OD4122background sample OD412)/(total lysis
sample OD4122background sample OD412).
Confocal microscopy analysis. Confocal microscopy analyses
RESULTS
As mentioned above, BoHV-4 has several intrinsic features
that make it attractive as a backbone for a viral vector and/or
as a model to study gammaherpesvirus biology. However,
these developments have been impeded by the difficulty of
Fig. 2. Characterization of BoHV-4 BAC plasmids and derived strains. (a) Characterization of BoHV-4 BAC plasmids and
derived BoHV-4 strains by a combined restriction endonuclease/Southern blot approach. V. test BAC G and V. test BAC I
plasmids and the genome of BoHV-4 V. test BAC G, V. test BAC I, V. test BAC G excised and V. test BAC I excised strains
were analysed by HindIII restriction (left panels) and further tested by Southern blotting using a probe corresponding to nt
14309940 of the modified pBeloBAC plasmid (right panels). Arrows indicate restriction fragments containing the BAC
cassette. Marker sizes (MS) in kb are indicated on the left. (b) Characterization of BoHV-4 strains derived from BoHV-4 BAC
plasmids by confocal analysis of viral plaques. MDBK cells grown on glass coverslips were infected with BoHV-4 wild-type V.
test (iiii), V. test BAC G (ivvi) and V. test BAC G excised (viiix) strains and then overlaid with MEM containing 5 % FCS
and 0?6 % (w/v) carboxymethylcellulose (Sigma-Aldrich) to obtain isolated plaques. Three days after infection, plaques were
revealed by indirect immunofluorescent staining using mAb 35 and PE-conjugated goat anti-mouse Ig as the primary and
secondary antibodies, respectively. Each set of three horizontal panels (iiii, ivvi and viiix) represents analysis of the same
plaques. EGFP fluorescence is shown in (i), (iv) and (vii), and PE fluorescence in (ii), (v) and (viii). The merged EGFP and PE
signals are shown in (iii), (vi) and (ix). The side of each panel corresponds to 75 mm. Similar results were obtained with the
strains derived from V. test BAC I plasmid (data not shown). (c) Replication kinetics of BoHV-4 strains derived from BoHV-4
BAC plasmids compared with the parental BoHV-4 V. test strain, determined as described in Methods. The data presented
are the means of triplicate measurements.
http://vir.sgmjournals.org
911
Fig. 3. Production of BoHV-4 recombinant strains expressing IRAC I or II by mutagenesis of V. test BAC G plasmid in
bacteria. (a) The IRAC I or II expression cassette was inserted in the BstEII site of the V. test BAC G plasmid corresponding
to the far left BstEII site of BoHV-4 L-DNA. The insertion was performed by homologous recombination between V. test BAC
G and pST76KSR-lacZ IRAC I or II plasmids. (b) Flowchart of stages performed to produce BoHV-4 strains expressing IRAC
I or II.
DISCUSSION
BAC cloning has speeded up fundamental and applied
research on several herpesviruses. In the present study, we
BAC cloned the BoHV-4 genome and demonstrated the
quality of the plasmids obtained for production of BoHV-4
recombinants using prokaryotic recombination technology.
The recombinants produced were used to illustrate the
potential of BoHV-4 as an in vitro expression vector.
The BoHV-4 BAC plasmids produced in this study exhibited several interesting features for the production of
BoHV-4 recombinant vectors. Firstly, it was possible to
propagate them stably in bacteria for at least 720 generations. Despite this relative high number, recombination
events were not detected, as described, for example, for
murid herpesvirus 4 BAC (Adler et al., 2000). Secondly,
infectious BoHV-4 recombinant viruses could be efficiently
reconstituted by transfection of the BoHV-4 BAC plasmid
into permissive cells. This feature contrasts with HCMV
(Borst et al., 1999) BAC plasmids, which required the
expression of transactivating factor for efficient production
of virions, and with BoHV-1 (Mahony et al., 2002) and
herpes simplex virus 1 (Stavropoulos & Strathdee, 1998)
BAC plasmids requiring drug treatment to promote IE
gene expression. Thirdly, a major advantage of herpesvirus
vectors is their very large cloning capacity when compared
with other viral vectors (Kootstra & Verma, 2003; Pfeifer &
Verma, 2001; Verma & Somia, 1997). The data presented
in this study demonstrated that at least 10?5 kb of foreign
DNA could be inserted into the BoHV-4 wild-type genome
without affecting its replication properties (Fig. 4b).
The present study illustrates the potential of BoHV-4 as
an in vitro expression vector. However, several properties
of BoHV-4 make it a good candidate for the development
of recombinant vaccines for cattle. Firstly, in contrast to
BoHV-1, there is no eradication scheme against BoHV-4.
Secondly, bovine monocytes and macrophages support
BoHV-4 replication (M. Lambot, unpublished data) suggesting that expression of the transgene in those cells should
913
Fig. 4. Characterization of BoHV-4 recombinant strains expressing IRAC I or II. (a) Characterization of BoHV-4 recombinant
strains expressing IRACs using a combined restriction endonuclease/Southern blot approach. The DNA of the various
intermediates described in Fig. 3(b) was analysed by HindIII restriction (left panel) and further tested by Southern blotting
using IRAC I or II ORF probes (middle and right panels). Arrows indicate the restriction fragments containing IRAC ORFs.
Marker sizes (MS) in kb are indicated on the left. (b) Immunodetection of IRACs expressed by BoHV-4 recombinant strains.
MDBK cells were infected at an m.o.i. of 0?01 with BoHV-4 V. test BAC G IRAC I (iiii), V. test BAC G IRAC I excised (ivvi),
V. test BAC G IRAC II (viiix) and V. test BAC G IRAC II excised (xxii) strain. After an incubation period of 48 h at 37 6C,
cells were analysed by indirect immunofluorescent staining as described in Methods. Anti-IRAC I (ivi) and anti-IRAC II (viixii)
mouse sera were used as primary antibodies and revealed using PE-conjugated goat anti-mouse secondary antibodies. Cells
were then examined by confocal microscopy for EGFP (i, iv, vii and x) and R-PE (ii, v, viii and xi) signals. The merged EGFP
and R-PE signals are shown in (iii), (vi), (ix) and (xii). The side of each panel corresponds to 150 mm.
914
Fig. 5. Ability of IRAC molecules expressed by BoHV-4 recombinants to inhibit the alternative pathway of the complement
system. MDBK and 293T cells grown in 75 cm2 flask were transfected with pEGFP-N1 or pcDNA4-TO IRAC I or II plasmids,
or infected at an m.o.i. of 1 p.f.u. per cell with BoHV-4 V. test, V. test BAC G IRAC I excised or V. test BAC G IRAC II excised
strain. Forty-eight hours after transfection or infection, cell-culture supernatants were collected and concentrated. Proteins
contained in 5 ml of concentrated supernatants were resolved by SDS-PAGE, blotted and detected with anti-IRAC I or
anti-IRAC II mouse sera as described in Methods. The ability of concentrated cell supernatants to inhibit the alternative
complement pathway was determined by the addition of various amounts of concentrated cell supernatant to the test. Data
are expressed as the percentage of lysis observed compared with the addition of mock-transfected or mock-infected
concentrated cell supernatant and represent the means of triplicate measures. SDs were lower than 0?2.
cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes. J Virol 74, 77207729.
Kootstra, N. A. & Verma, I. M. (2003). Gene therapy with viral
ACKNOWLEDGEMENTS
A. V., N. M.-G. and L. G. are a Senior Research Associate, Postdoctoral
Researcher and Research Fellow of the Fonds National Belge de la
Recherche Scientifique (FNRS), respectively. Thanks are due to Dr
D. Pirottin (University of Lie`ge, Belgium) and Dr M. Parmentier (Free
University of Brussels, Belgium) for providing the pGBF-NLS-Cre
and pEFIN3 plasmids, respectively. This work was supported by
the following grants: Recherche dinitiative du Ministe`re de la
Region Wallonne programme no. 14628 convention 315543 Region
Wallonne and Service public et Federal sante publique, securite
de la chane alimentaire et environnement (Belgium) programme
no. S-6146. M. W. and U. H. K. were supported by the Deutsche
Forschungsgemeinschaft through SBF 455. M. W. is supported by a
Human Frontiers Science Program long-term fellowship.
REFERENCES
herpesvirus-3 from African buffaloes (Syncerus caffer). Res Vet Sci 46,
337343.
Suter, M., Lew, A. M., Grob, P., Adema, G. J., Ackermann, M.,
Shortman, K. & Fraefel, C. (1999). BAC-VAC, a novel generation of
916
dun herpesvirus chez un taureau infertile. Ann Med Vet 125, 143.
Thiry, E., Bublot, M., Dubuisson, J., Van Bressem, M. F., Lequarre,
A. S., Lomonte, P., Vanderplasschen, A. & Pastoret, P. P. (1992).
http://vir.sgmjournals.org
917